Profil
Suba Krishnan formerly worked at The Trustees of Columbia University in The City of New York, as Assistant Professor, Genmab A, as Global Program Head-Immuno-Oncology from 2019 to 2020, and Mereo BioPharma Group Plc, as Senior Vice President-Clinical Development.
Dr. Krishnan received her doctorate degree from Weill Cornell Medical College and undergraduate degree and doctorate degree from Armed Forces Medical College.
Anciens postes connus de Suba Krishnan
| Sociétés | Poste | Fin |
|---|---|---|
| GENMAB A/S | Corporate Officer/Principal | 01/11/2020 |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| MEREO BIOPHARMA GROUP PLC | Directeur Technique/Scientifique/R&D | - |
Formation de Suba Krishnan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genmab A/S
Genmab A/S BiotechnologyHealth Technology Operates as a biotechnology company for improving the lives of people with cancer and serious diseases through antibody medicines | Health Technology |
Weill Cornell Medical College
Weill Cornell Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Armed Forces Medical College
Armed Forces Medical College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mereo BioPharma Group Plc
Mereo BioPharma Group Plc BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
















